CARRIE SUMNER: Open Payments
NPI 1851915938 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 35 payments from 14 companies in 2025. Trend: 2023 $37 · 2024 $461 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $137 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Dexcom, Inc. | 3 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| Lilly USA, LLC | 3 | $51 |
| PFIZER INC. | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Dexcom G6 Transmitter, CAPLYTA, FARXIGA, Rybelsus, MOUNJARO, Ozempic, BREZTRI, ELIQUIS.
Industry payments across GA — which companies pay providers there.
